Status:

UNKNOWN

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Lead Sponsor:

Sheba Medical Center

Collaborating Sponsors:

Lundbeck Israel

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to assess the effect of escitalopram on sleep architecture utilizing a prospective design. Hypothesis: Escitalopram will improve REM latency in patients with MDD that hav...

Detailed Description

Disturbance of sleep is a prominent symptom in depressive disorders. Alterations of sleep patterns in depressed patients include insomnia, frequent awakenings, early wake-up and non-refreshing sleep. ...

Eligibility Criteria

Inclusion

  • Patients suffering from MDD, excluding a depressive episode of Bipolar Disorder.
  • The depressive episode is not secondary to a general medical condition or substance abuse.
  • Ages between 18-65 years old.
  • Patients receiving other medications must be on a stable dosage for one month before entering the trial, including hypnotics.
  • Able to understand and sign an informed consent form.

Exclusion

  • Patients suffering from sleep disturbances due to a physical condition (COPD, sleep apnea or essential insomnia preceding the diagnosis of depression).
  • Patients suffering from an unstable clinically significant medical condition (cardiovascular, endocrine, nutritional, hepatic, urinary).
  • Patients suffering from a malignancy or neuro-degenerative such as Parkinsons' disease
  • Patients suffering from a clinically significant psychiatric psychotic disease, as judged by DSM-IV criteria, such as schizophrenia or acute psychosis.
  • Patients experiencing severe withdrawal symptoms following a discontinuation of hypnotic drugs, upon entry into the baseline phase.
  • History of drug or alcohol dependence within the last year.

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00442481

Start Date

February 1 2007

Last Update

March 2 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sheba Medical Center, Department of psychiatry

Tel Litwinsky, Israel